July 05 | 6 Strong Buy Health Technology Stocks On Watchlist

This is a must read [707% Growth For American Lithium Company After They Fight Back Against China]( [They've Already Seen 707% Growth In 2021, And That Could Just Be The Start]( --------------------------------------------------------------- Dear Reader, We have identified 6 'Strong Buy' Health Technology Trade Stocks that you might want to keep an eye on....Keep in mind, these are very volatile stocks so please do your own research before you make any investments. We are not recommending these stocks but they are certainly getting positive attention from analysts. --------------------------------------------------------------- [Copper More Critical than Lithium?]() =Lithium may have grabbed the headlines as a key material in building electric vehicles (EVs). But so is copper. And copper's importance in the new green economy goes far beyond EVs. Copper is critical in building wind turbines and solar panels. It's key to power lines and upgrading the national grid. Analysts say we're facing a 10-million-ton shortfall if new copper mines are not found. [See How You Can Benefit From New Copper Discoveries.]() --------------------------------------------------------------- See the list below. [Arcutis Biotherapeutics, ARQT](=) - Buy to Strong Buy [TipRanks.com]() also reports that [Arcutis Biotherapeutics]() currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $47.75. The target pricing ranges from a high forecast of $57.00 down to a low forecast of $39.00. [Arcutis Biotherapeutics (ARQT)](=)’s last closing price was $$21.97 which would put the average price target at 117.34% upside. Based on 3rd party rating services including: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy Our research team shows Yahoo! Finance with a Bullish Short-Term Outlook and Barchart.com with a Strong buy rating. [Click for chart >>]( = ----------------------------------------------------- [Axonics Modulation Technologies, AXNX]() - Buy to Strong Buy [TipRanks.com]() also reports that [Axonics Modulation Technologies]() currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $72.25. The target pricing ranges from a high forecast of $80.00 down to a low forecast of $60.00. [Axonics Modulation Technologies (AXNX)](=)’s last closing price was $$58.87 which would put the average price target at 22.73% upside. Based on 3rd party rating services including: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy Our research team shows Yahoo! Finance with a Bullish Short-Term Outlook and Barchart.com with a Weak buy rating. [Click for chart >>]() ----------------------------------------------------- --------------------------------------------------------------- [Gold explodes past $2,000, here's what's next]() After what feels like nearly a decade of disappointing returns, gold is entering a major bull market. You can get started today for less than $10. --------------------------------------------------------------- [Amylyx Pharmaceuticals Inc, AMLX]() - Buy to Strong Buy [TipRanks.com]( also reports that [Amylyx Pharmaceuticals Inc]() currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $33.00. The target pricing ranges from a high forecast of $35.00 down to a low forecast of $31.00. [Amylyx Pharmaceuticals Inc (AMLX)]()’s last closing price was $$21.68 which would put the average price target at 52.21% upside. Based on 3rd party rating services including: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy Our research team shows Yahoo! Finance with a Bearish Short-Term Outlook and Barchart.com with a n/a rating. [Click for chart >>](=) ----------------------------------------------------- [United Therapeutics, UTHR](=) - Buy to Strong Buy [TipRanks.com]() also reports that [United Therapeutics]( currently has 10 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $254.22. The target pricing ranges from a high forecast of $300.00 down to a low forecast of $238.00. [United Therapeutics (UTHR)](’s last closing price was $$234.63 which would put the average price target at 8.35% upside. Based on 3rd party rating services including: - TipRanks.com: Strong Buy - TradingView.com: Buy Our research team shows Yahoo! Finance with a Bearish Short-Term Outlook and Barchart.com with a Strong buy rating. [Click for chart >>](=) = ----------------------------------------------------- --------------------------------------------------------------- [Where Should Investors Look Next in 2022?](=) =There’s a secret market few people know about that’s been responsible for some of the [greatest wealth opportunities]( in history. Today, it’s the number-one job creator in America and is responsible for $3 trillion in new wealth every year. [We’re going live with the full story here.]( = --------------------------------------------------------------- [Shockwave Medical, SWAV]() - Buy to Strong Buy [TipRanks.com]() also reports that [Shockwave Medical]() currently has 6 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $186.83. The target pricing ranges from a high forecast of $245.00 down to a low forecast of $155.00. [Shockwave Medical (SWAV)]()’s last closing price was $$196.62 which would put the average price target at -4.98% upside. Based on 3rd party rating services including: - TipRanks.com: Strong Buy - TradingView.com: Buy Our research team shows Yahoo! Finance with a Bullish Short-Term Outlook and Barchart.com with a buy rating. [Click for chart >>]() ----------------------------------------------------- [Day One Biopharmaceuticals, DAWN]( - Buy to Strong Buy [TipRanks.com]() also reports that [Day One Biopharmaceuticals](=) currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $37.50. The target pricing ranges from a high forecast of $40.00 down to a low forecast of $35.00. [Day One Biopharmaceuticals (DAWN)](=)’s last closing price was $$19.5 which would put the average price target at 92.31% upside. Based on 3rd party rating services including: - TipRanks.com: Strong Buy - TradingView.com: Buy Our research team shows Yahoo! Finance with a Bullish Short-Term Outlook and Barchart.com with a Weak buy rating. [Click for chart >>](=) ----------------------------------------------------- Pricing & Percentages as of approximately 10:00am EST. [TipRanks.com]() tracks and measures the performance of over 50,000 financial experts. The TipRanks Star Ranking TM is calculated based on expert success rate, average return and statistical significance. [Get more from TipRanks.com here >>]() --------------------------------------------------------------- ["The Most Critical Metal for Global Economies"]() The soaring demand for this "red rock" may be the most important development in 2022. It's key in the transition to the new green energy economies. Bloomberg News warns… "Within a decade, the world may face a massive shortfall of what's arguably the most critical metal for global economies." Copper prices have nearly doubled in the past year. [Find Out How This Is Good News for Commodity Investors.]() --------------------------------------------------------------- [Unsubscribe]( Sandpiper Marketing Group, LLC PO Box 407 Mt. Mourne, North Carolina 28123 United States (845) 803-0954 If you no longer wish to receive our emails, click the link below: [Unsubscribe]( Sandpiper Marketing Group, LLC PO Box 407 Mt. Mourne, North Carolina 28123 United States (845) 803-0954